Below are links to the PubMed listings of various references to read for additional information


Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.
Kotton CN, Kumar D, Caliendo AM, et al. Transplantation. 2013;96(4):333-360.
International Survey of Cytomegalovirus Management in Solid Organ Transplantation After the Publication of Consensus Guidelines.
Le Page AK, Jager MM, Kotton CN, Simoons-Smit A, Rawlinson WD. Transplantation Journal. 2013;95(12):1455-1460.
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.
Tomblyn M, Chiller T, Einsele H, et al. Biol Blood Marrow Transplant. 2009 Oct;15(10):1143-238.


Cytomegalovirus in liver transplant recipients.
Herman D., Han H. Curr Opin Organ Transplant. 2017 Aug; 22(4): 345-350.
Immunotherapy for transplantation-associated viral infections.
Roddie C, Peggs K et al. J Clin Invest. 2017 Jun 19. pii: 90599. doi: 10.1172/JCI90599. [Epub ahead of print]
Identifying Cytomegalovirus (CMV) complications using the Quantiferon-CMV assay after Allogeneic Hematopoietic Stem Cell Transplantation.
Yong MK, Cameron PU, et al. Journal of Infectious Diseases 2017 Apr 18.[Epub ahead of print]
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.
Banas B, Böger CA, Lückhoff G, et al. BMC Immunol 2017 Mar 7;18(1):15.doi: 10.1186/s12865-017-0194-z
Cytomegalovirus-Responsive CD8+ T Cells Expand After Solid Organ Transplantation in the Absence of CMV Disease.
Higdon LE, Trofe-Clark J, Liu S, et al. Am J Transplant 2017 Feb 15.[Epub ahead of print]
Cytomegalovirus responsive CD8+ T cells expand after solid organ transplantation in the absence of CMV disease.
Higdon LE, Trofe-Clark J, Liu S, et al. Am J Transplant. 2017 Feb 15. [Epub ahead of print]
Back to Top